Capstone Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $234K | Sell |
6,910
-760
| -10% | -$25.7K | 0.01% | 1423 |
|
|
2017
Q1 | $223K | Sell |
7,670
-1,060
| -12% | -$30.8K | 0.01% | 1478 |
|
|
2016
Q4 | $287K | Sell |
8,730
-7,280
| -45% | -$239K | 0.01% | 1343 |
|
|
2016
Q3 | $505K | Buy |
16,010
+30
| +0.2% | +$946 | 0.01% | 959 |
|
|
2016
Q2 | $449K | Buy |
15,980
+2,420
| +18% | +$68K | 0.01% | 996 |
|
|
2016
Q1 | $493K | Sell |
13,560
-100
| -0.7% | -$3.64K | 0.01% | 929 |
|
|
2015
Q4 | $547K | Buy |
13,660
+3,960
| +41% | +$159K | 0.02% | 862 |
|
|
2015
Q3 | $276K | Buy |
9,700
+870
| +10% | +$24.8K | 0.01% | 1296 |
|
|
2015
Q2 | $291K | Sell |
8,830
-4,730
| -35% | -$156K | 0.01% | 1318 |
|
|
2015
Q1 | $390K | Buy |
13,560
+1,190
| +10% | +$34.2K | 0.01% | 1247 |
|
|
2014
Q4 | $337K | Sell |
12,370
-1,590
| -11% | -$43.3K | 0.01% | 1306 |
|
|
2014
Q3 | $297K | Hold |
13,960
| – | – | 0.01% | 1363 |
|
|
2014
Q2 | $314K | Buy |
13,960
+2,356
| +20% | +$53K | 0.01% | 1362 |
|
|
2014
Q1 | $293K | Sell |
11,604
-250
| -2% | -$6.31K | 0.01% | 1430 |
|
|
2013
Q4 | $273K | Sell |
11,854
-120
| -1% | -$2.76K | 0.01% | 1581 |
|
|
2013
Q3 | $228K | Buy |
11,974
+400
| +3% | +$7.62K | 0.01% | 1796 |
|
|
2013
Q2 | $167K | Buy |
+11,574
| New | +$167K | ﹤0.01% | 1827 |
|